ZyVersa Therapeutics (ZVSA) Stock Chart & Stock Price History $0.16 -0.01 (-5.55%) As of 02:53 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZyVersa Therapeutics Stock Price Performance The ZyVersa Therapeutics (ZVSA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 95.40%, with a year-to-date return of -85.38%. In the past month, the stock has decreased 76.93%, reflecting recent market activity. As of the latest close, ZyVersa Therapeutics traded at $0.16 with a market cap of $800 thousand and volume of 21,255 shares. Receive ZVSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-16.35%1 Month Performance-76.93%3 Month Performance-71.88%Year-To-Date Performance-85.38%1 Year Performance-95.40% ZVSA Stock Chart for Wednesday, August, 6, 2025 ZVSA Chart by TradingView ZyVersa Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/06/2025$0.16$0.16-5.55%$0.17$0.1641,721 shs$755,000.0008/05/2025$0.18$0.16-8.93%$0.18$0.1621,255 shs$800,000.0008/04/2025$0.19$0.18-2.75%$0.22$0.1829,292 shs$878,000.0008/01/2025$0.20$0.19-6.84%$0.23$0.1819,573 shs$902,000.0007/31/2025$0.20$0.20-0.55%$0.23$0.1843,948 shs$969,000.0007/30/2025$0.25$0.20-20.57%$0.25$0.1977,419 shs$974,000.0007/29/2025$0.26$0.25-1.25%$0.27$0.2364,062 shs$1.23 million07/28/2025$0.27$0.26-5.56%$0.28$0.22359,873 shs$1.24 million07/25/2025$0.24$0.27+12.50%$0.28$0.24111,662 shs$1.32 million07/24/2025$0.24$0.24+2.13%$0.29$0.22522,706 shs$1.17 million Get the Latest News and Ratings for ZVSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025$0.15$0.24+59.32%$0.25$0.15622,469 shs$1.15 million07/22/2025$0.14$0.15+4.98%$0.16$0.13275,589 shs$719,000.0007/21/2025$0.14$0.14-1.75%$0.17$0.12406,361 shs$685,000.0007/18/2025$0.18$0.14-22.54%$0.19$0.14635,472 shs$696,000.0007/17/2025$0.31$0.18-40.70%$0.25$0.151.71 million shs$900,000.0007/16/2025$0.55$0.31-43.30%$0.56$0.2711.92 million shs$1.52 million07/15/2025$0.57$0.55-3.31%$0.56$0.53466,579 shs$2.62 million07/14/2025$0.59$0.57-3.76%$0.57$0.55702,720 shs$2.71 million07/11/2025$0.59$0.59$0.59$0.561.07 million shs$2.82 million07/10/2025$0.64$0.59-7.81%$0.67$0.561.76 million shs$2.81 million07/09/2025$0.78$0.64-17.42%$0.70$0.624.22 million shs$3.05 million07/08/2025$0.66$0.78+17.37%$1.67$0.70207.52 million shs$3.70 million07/07/2025$0.67$0.66-1.74%$0.69$0.65158,566 shs$3.15 million Related Companies SPRB Stock Price Chart VRAX Stock Price Chart ALBT Stock Price Chart CMND Stock Price Chart QLGN Stock Price Chart EVAX Stock Price Chart SNGX Stock Price Chart REVB Stock Price Chart THAR Stock Price Chart SPRC Stock Price Chart Receive ZVSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ZVSA) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredDebt Crisis Warning: How to Protect Your Wealth Before August 31stOn August 31st, the U.S. runs out of “extraordinary measures” to avoid default—and Washington insiders are alr...American Alternative | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZVSA Stock Alerts